Crossmark

Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosis

Crossref DOI link: https://doi.org/10.1186/s12982-017-0067-1

Published Online: 2017-11-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Dan https://orcid.org/0000-0003-0705-715X
Keogh, Ruth

Clancy, John P.

Szczesniak, Rhonda D.
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (K25 HL125954)

Cystic Fibrosis Foundation Therapeutics (R457-CR11)
License Information

Text and Data Mining valid from 2017-11-14

Version of Record valid from 2017-11-14
More Information

Article History

Received: 11 April 2017

Accepted: 3 November 2017

First Online: 14 November 2017

Document is current

Any future updates will be listed below